back-ups and second generation of TLR2 antagonist (Neuropore Therapeutics)

N/A

Report date: 2025/01/26 15:01:56
NME

Base Information

Drug Nameback-ups and second generation of TLR2 antagonist (Neuropore Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 2 inhibitors
TargetsToll like receptor 2
Therapy Area/IndicationsNeuritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuropore Therapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeuropore Therapies Inc
Inactive CompaniesN/A
Active IndicationsNeuritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A